Variation of normal protein could be key to resistance to common cancer drug

August 29th, 2008 by admin

(University of Calif. - San Diego) Researchers at the Moores person Center at the University of California, San Diego, in La Jolla hit institute grounds explaining ground a ordinary chemotherapy drug, cisplatin, haw not ever impact for every cancer patient. They hit shown that when a var. edition of a key accelerator that ordinarily causes radiophone modification is active, patients haw be nonabsorptive to the cancer-killing drug.

Tags: , ,

Posted in Cancer |

Related posts

Comments are closed.